These data, together with the fact that CB1 can exert anti-proliferative actions in human keratinocytes [174], suggested that CB1 and CB2 may exhibit certain anti-tumor actions in non-melanoma skin cancers as well. This evidence concerns the gene CNR2 and neoplasm.